Skip to main content

. 1974 Oct;67(10):1073–1075. doi: 10.1177/003591577406701049

Management of sickle cell disorders.

PMCID: PMC1646061 PMID: 4427910

1073

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cerami A., Manning J. M. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1180–1183. doi: 10.1073/pnas.68.6.1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
HUGH-JONES K., LEHMANN H., MCALISTER J. M. SOME EXPERIENCES IN MANAGING SICKLE-CELL ANAEMIA IN CHILDREN AND YOUNG ADULTS, USING ALKALIS AND MAGNESIUM. Br Med J. 1964 Jul 25;2(5403):226–229. doi: 10.1136/bmj.2.5403.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hatch F. E., Culbertson J. W., Diggs L. W. Nature of the renal concentrating defect in sickle cell disease. J Clin Invest. 1967 Mar;46(3):336–345. doi: 10.1172/JCI105535. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES